"Fluoxymesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anabolic steroid that has been used in the treatment of male HYPOGONADISM, delayed puberty in males, and in the treatment of breast neoplasms in women.
| Descriptor ID |
D005474
|
| MeSH Number(s) |
D04.210.500.054.079.429.154.349 D04.210.500.908.466
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluoxymesterone".
Below are MeSH descriptors whose meaning is more specific than "Fluoxymesterone".
This graph shows the total number of publications written about "Fluoxymesterone" by people in this website by year, and whether "Fluoxymesterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluoxymesterone" by people in Profiles.
-
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Res Treat. 2016 11; 160(1):101-109.
-
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology. 2007 Jan; 148(1):363-73.
-
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. J Clin Oncol. 1998 May; 16(5):1669-76.
-
Adult height in girls with Turner syndrome treated with low-dose estrogens and androgens. Ann Pharmacother. 1994 May; 28(5):570-1.
-
Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood. 1985 Jul; 66(1):184-8.
-
Pure red cell aplasia characterized by erythropoietic maturation arrest. Response to anti-thymocyte globulin. Am J Med. 1985 Mar; 78(3):515-7.
-
Results of four years of intermittent human growth hormone (hGH) and fluoxymesterone therapy in hypopituitary dwarfism. Pediatrics. 1980 Mar; 65(3):562-6.
-
Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism. Pediatrics. 1979 Mar; 63(3):386-8.